Imported in vitro diagnostics to be waived from reporting

Raw materials that will not be directly imported by drug manufacturers, including in vitro diagnostics, will be excluded from mandatory reporting to the Korea Food and Drug Administration from next year.

KFDA officials said these items may be imported based on foreign manufacturer’s certificate of analysis.

Under the newly revised regulations, traders or sub-dividing companies are also ob...